{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Phensuximide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Phensuximide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Phensuximide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "phensuximide",
    "trial_2_text": "Phensuximide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Phensuximide Supplement: 60 participants will take Phensuximide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Phensuximide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Phensuximide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "9": 0.2059970200061798,
      "17": 0.19273975491523743,
      "87": 0.18997952342033386,
      "78": 0.18284080922603607,
      "173": 0.15184886753559113,
      "177": 0.1502368301153183,
      "77": 0.13931697607040405,
      "68": 0.13336780667304993,
      "20": 0.13285624980926514,
      "79": 0.1323380470275879,
      "123": 0.13135114312171936,
      "21": 0.1284734308719635,
      "14": 0.12743529677391052,
      "228": 0.12223958224058151,
      "49": 0.11597085744142532,
      "46": 0.11391624063253403,
      "189": 0.11247110366821289,
      "37": 0.10955904424190521,
      "188": 0.10078530758619308,
      "67": 0.09795987606048584,
      "200": 0.09397168457508087,
      "2": 0.09143330901861191,
      "350": 0.08778729289770126,
      "114": 0.08657973259687424,
      "101": 0.08655648678541183,
      "29": 0.0840555876493454,
      "151": 0.08328846096992493,
      "76": 0.08012623339891434,
      "104": 0.08010198920965195,
      "64": 0.0800156369805336,
      "239": 0.0781412422657013,
      "86": 0.07683544605970383,
      "180": 0.0727078840136528,
      "30": 0.0722617655992508,
      "85": 0.0709245428442955,
      "193": 0.06943371146917343,
      "28": 0.06495330482721329,
      "243": 0.06410074979066849,
      "61": 0.0636354610323906,
      "102": 0.06359358131885529,
      "131": 0.06295949965715408,
      "116": 0.0622808076441288,
      "126": 0.06092658266425133,
      "72": 0.0599234513938427,
      "139": 0.05799684673547745,
      "132": 0.057938553392887115,
      "466": 0.057670995593070984,
      "18": 0.0560738779604435,
      "5": 0.05572902783751488,
      "27": 0.05430569872260094,
      "396": 0.05209801346063614,
      "276": 0.05197001248598099,
      "147": 0.04957389086484909,
      "269": 0.049016304314136505,
      "262": 0.048935916274785995,
      "164": 0.046179499477148056,
      "179": 0.04529108852148056,
      "194": 0.04502243176102638,
      "82": 0.04473661258816719,
      "69": 0.04458159953355789,
      "92": 0.044538795948028564,
      "38": 0.0444234274327755,
      "144": 0.043514642864465714,
      "11": 0.04285438358783722,
      "253": 0.04213273897767067,
      "75": 0.0418044812977314,
      "422": 0.04153550788760185,
      "341": 0.04133160412311554,
      "261": 0.0412953682243824,
      "15": 0.04042021930217743,
      "122": 0.04023949056863785,
      "96": 0.0400196872651577,
      "1": 0.039995111525058746,
      "204": 0.03958354890346527,
      "456": 0.03927583247423172,
      "36": 0.03922980651259422,
      "355": 0.03909403458237648,
      "441": 0.038892898708581924,
      "191": 0.038252636790275574,
      "242": 0.03807052597403526,
      "282": 0.03792213648557663,
      "394": 0.03782491013407707,
      "66": 0.037713535130023956,
      "221": 0.037319932132959366,
      "286": 0.037181731313467026,
      "153": 0.03646356239914894,
      "199": 0.036339208483695984,
      "98": 0.03629012405872345,
      "33": 0.03616504743695259,
      "361": 0.035831473767757416,
      "234": 0.0357627272605896,
      "186": 0.0356503427028656,
      "97": 0.03561732545495033,
      "138": 0.03505954146385193,
      "508": 0.03478149697184563,
      "345": 0.03444333374500275,
      "166": 0.034378424286842346,
      "35": 0.033914901316165924,
      "288": 0.03383638709783554,
      "130": 0.03373892232775688
    },
    "trial_2_ae": {
      "9": 0.2059970200061798,
      "17": 0.19273975491523743,
      "87": 0.18997952342033386,
      "78": 0.18284080922603607,
      "173": 0.15184886753559113,
      "177": 0.1502368301153183,
      "77": 0.13931697607040405,
      "68": 0.13336780667304993,
      "20": 0.13285624980926514,
      "79": 0.1323380470275879,
      "123": 0.13135114312171936,
      "21": 0.1284734308719635,
      "14": 0.12743529677391052,
      "228": 0.12223958224058151,
      "49": 0.11597085744142532,
      "46": 0.11391624063253403,
      "189": 0.11247110366821289,
      "37": 0.10955904424190521,
      "188": 0.10078530758619308,
      "67": 0.09795987606048584,
      "200": 0.09397168457508087,
      "2": 0.09143330901861191,
      "350": 0.08778729289770126,
      "114": 0.08657973259687424,
      "101": 0.08655648678541183,
      "29": 0.0840555876493454,
      "151": 0.08328846096992493,
      "76": 0.08012623339891434,
      "104": 0.08010198920965195,
      "64": 0.0800156369805336,
      "239": 0.0781412422657013,
      "86": 0.07683544605970383,
      "180": 0.0727078840136528,
      "30": 0.0722617655992508,
      "85": 0.0709245428442955,
      "193": 0.06943371146917343,
      "28": 0.06495330482721329,
      "243": 0.06410074979066849,
      "61": 0.0636354610323906,
      "102": 0.06359358131885529,
      "131": 0.06295949965715408,
      "116": 0.0622808076441288,
      "126": 0.06092658266425133,
      "72": 0.0599234513938427,
      "139": 0.05799684673547745,
      "132": 0.057938553392887115,
      "466": 0.057670995593070984,
      "18": 0.0560738779604435,
      "5": 0.05572902783751488,
      "27": 0.05430569872260094,
      "396": 0.05209801346063614,
      "276": 0.05197001248598099,
      "147": 0.04957389086484909,
      "269": 0.049016304314136505,
      "262": 0.048935916274785995,
      "164": 0.046179499477148056,
      "179": 0.04529108852148056,
      "194": 0.04502243176102638,
      "82": 0.04473661258816719,
      "69": 0.04458159953355789,
      "92": 0.044538795948028564,
      "38": 0.0444234274327755,
      "144": 0.043514642864465714,
      "11": 0.04285438358783722,
      "253": 0.04213273897767067,
      "75": 0.0418044812977314,
      "422": 0.04153550788760185,
      "341": 0.04133160412311554,
      "261": 0.0412953682243824,
      "15": 0.04042021930217743,
      "122": 0.04023949056863785,
      "96": 0.0400196872651577,
      "1": 0.039995111525058746,
      "204": 0.03958354890346527,
      "456": 0.03927583247423172,
      "36": 0.03922980651259422,
      "355": 0.03909403458237648,
      "441": 0.038892898708581924,
      "191": 0.038252636790275574,
      "242": 0.03807052597403526,
      "282": 0.03792213648557663,
      "394": 0.03782491013407707,
      "66": 0.037713535130023956,
      "221": 0.037319932132959366,
      "286": 0.037181731313467026,
      "153": 0.03646356239914894,
      "199": 0.036339208483695984,
      "98": 0.03629012405872345,
      "33": 0.03616504743695259,
      "361": 0.035831473767757416,
      "234": 0.0357627272605896,
      "186": 0.0356503427028656,
      "97": 0.03561732545495033,
      "138": 0.03505954146385193,
      "508": 0.03478149697184563,
      "345": 0.03444333374500275,
      "166": 0.034378424286842346,
      "35": 0.033914901316165924,
      "288": 0.03383638709783554,
      "130": 0.03373892232775688
    }
  },
  "safety": {
    "trial_1_safety": 0.4330592155456543,
    "trial_2_safety": 0.4330592155456543
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48013919591903687
  }
}